These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38008730)

  • 21. A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England.
    Fulop NJ; Walton H; Crellin N; Georghiou T; Herlitz L; Litchfield I; Massou E; Sherlaw-Johnson C; Sidhu M; Tomini SM; Vindrola-Padros C; Ellins J; Morris S; Ng PL
    Health Soc Care Deliv Res; 2023 Jul; 11(13):1-151. PubMed ID: 37800997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to "Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in wales? Results of EVITE immunity, a linked data retrospective study" [Public Health 218 (2023) 12-20].
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Dale J; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 Sep; 222():229. PubMed ID: 37463828
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost of managing patients with venous leg ulcers.
    Phillips CJ; Humphreys I; Thayer D; Elmessary M; Collins H; Roberts C; Naik G; Harding K
    Int Wound J; 2020 Aug; 17(4):1074-1082. PubMed ID: 32383324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gwên am Byth: a programme introduced to improve the oral health of older people living in care homes in Wales - from anecdote, through policy into action.
    Howells EP; Davies R; Jones V; Morgan MZ
    Br Dent J; 2020 Dec; 229(12):793-799. PubMed ID: 33339930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    Zarif A; Joy M; Sherlock J; Sheppard JP; Byford R; Akinyemi O; Bankhead CR; Deeks A; Ferreira F; Jones N; Liyanage H; McGagh D; Nicholson B; Oke J; Okusi C; Tripathy M; Williams J; Hobbs R; de Lusignan S
    J Infect; 2021 Aug; 83(2):228-236. PubMed ID: 34004222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-benefit analysis of partnership working between fire and rescue and health services across England and Wales during the COVID-19 pandemic.
    Waring S; Jones A
    BMJ Open; 2023 Jul; 13(7):e072263. PubMed ID: 37438076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study.
    Bright D; Song J; Hillier S; Huws DW; Greene G; Hodgson K; Akbari A; Griffiths R; Davies AR; Gjini A
    Lancet; 2022 Nov; 400 Suppl 1():S25. PubMed ID: 36929968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales.
    Swann OV; Lone NI; Harrison EM; Tomlinson LA; Walker AJ; Seaborne MJ; Pollock L; Farrell J; Hall PS; Seth S; Williams TC; Preston J; Ainsworth JS; Semple FF; Baillie JK; Katikireddi SV; Akbari A; Lyons R; Simpson CR; Semple MG; Goldacre B; Brophy S; Sheikh A; Docherty AB
    BMJ Open; 2022 Nov; 12(11):e063271. PubMed ID: 36356998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and shielding: experiences of UK patients with lupus and related diseases.
    Sloan M; Gordon C; Lever E; Harwood R; Bosley MA; Pilling M; Brimicombe J; Naughton F; Blane M; Walia C; D'Cruz D
    Rheumatol Adv Pract; 2021; 5(1):rkab003. PubMed ID: 33728396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the cost of managing patients with cellulitis in Wales, UK: A 20-year population-scale study.
    Humphreys I; Akbari A; Griffiths R; Graham-Woollard D; Morgan K; Noble-Jones R; Gabe-Walters M; Thomas M
    Int Wound J; 2023 Aug; 20(6):2129-2140. PubMed ID: 36648008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using health impact assessment (HIA) to understand the wider health and well-being implications of policy decisions: the COVID-19 'staying at home and social distancing policy' in Wales.
    Green L; Ashton K; Azam S; Dyakova M; Clemens T; Bellis MA
    BMC Public Health; 2021 Jul; 21(1):1456. PubMed ID: 34315469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales.
    Alsallakh MA; Sivakumaran S; Kennedy S; Vasileiou E; Lyons RA; Robertson C; Sheikh A; Davies GA;
    BMC Med; 2021 May; 19(1):124. PubMed ID: 33993870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 risk factors amongst 14,786 care home residents: an observational longitudinal analysis including daily community positive test rates of COVID-19, hospital stays and vaccination status in Wales (UK) between 1 September 2020 and 1 May 2021.
    Hollinghurst J; Hollinghurst R; North L; Mizen A; Akbari A; Long S; Lyons RA; Fry R
    Age Ageing; 2022 May; 51(5):. PubMed ID: 35511729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac interventions in Wales: A comparison of benefits between NHS Wales specialties.
    Davies G; Akbari A; Bailey R; Evans L; Smith K; Goodfellow J; Thomas M; Lutchman Singh K
    PLoS One; 2024; 19(2):e0297049. PubMed ID: 38335178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom.
    Roberts G; Holmes J; Williams G; Chess J; Hartfiel N; Charles JM; McLauglin L; Noyes J; Edwards RT
    Perit Dial Int; 2022 Nov; 42(6):578-584. PubMed ID: 35068280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'We thank you for your sacrifice': Clinical vulnerability, shielding and biosociality in the UK's Covid-19 response.
    Herrick C
    Biosocieties; 2023; 18(1):218-240. PubMed ID: 35096124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of COVID-19 pandemic on incidence of long-term conditions in Wales: a population data linkage study using primary and secondary care health records.
    Qi C; Osborne T; Bailey R; Cooper A; Hollinghurst JP; Akbari A; Crowder R; Peters H; Law RJ; Lewis R; Smith D; Edwards A; Lyons RA
    Br J Gen Pract; 2023 May; 73(730):e332-e339. PubMed ID: 37105743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-Person and Telehealth Ambulatory Contacts and Costs in a Large US Insured Cohort Before and During the COVID-19 Pandemic.
    Weiner JP; Bandeian S; Hatef E; Lans D; Liu A; Lemke KW
    JAMA Netw Open; 2021 Mar; 4(3):e212618. PubMed ID: 33755167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology, healthcare and societal burden of basal cell carcinoma in Wales 2000-2018: a retrospective nationwide analysis.
    Ibrahim N; Jovic M; Ali S; Williams N; Gibson JAG; Griffiths R; Dobbs TD; Akbari A; Lyons RA; Hutchings HA; Whitaker IS
    Br J Dermatol; 2023 Feb; 188(3):380-389. PubMed ID: 36715329
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.